Vitamin B12
A deficiency that is easy to miss, because it can present with neurological symptoms before any change appears in a blood count, and because several common situations cause it quietly 1.
Last scientifically reviewed: November 22, 2026Editorial review: MDS Labs. External scientific review pending.
Commercial disclosure. MDS Labs does not currently sell a standalone B12 supplement. B12 is worth testing for if you are in one of the risk groups described below rather than taking on the assumption of a shortfall.
- Common names
- Vitamin B12; cobalamin; on labels cyanocobalamin, methylcobalamin, hydroxocobalamin or adenosylcobalamin
- Source
- Animal foods: meat, fish, eggs and dairy. Plant foods contain essentially none unless fortified
- Part used
- Not applicable: a water-soluble vitamin
- Key constituents
- Cobalamin, a cobalt-containing molecule
- Classification
- Essential water-soluble vitamin
- Traditional use
- Not applicable; its discovery followed work on pernicious anaemia
- US regulatory status
- Dietary supplement; also available as prescription injections for malabsorption
Human evidence, outcome by outcome
Graded per outcome. A strong result for one outcome says nothing about another.
Correcting a confirmed B12 deficiency
Established in humansReplacing B12 in demonstrated deficiency is standard treatment. The important clinical point is that deficiency can present with neurological features before anaemia appears, so it is identified by testing rather than inferred from a blood count 1.
Studied: Clinical review of diagnosis and management.
Limits: Applies to people with a confirmed deficiency. Neurological damage can be slow to reverse if correction is delayed, which is the argument for not waiting.
Testing in long-term metformin users
Established in humansLong-term metformin use is associated with vitamin B12 deficiency, making it one of the clearest cases where a prescribed medicine creates a specific reason to test 2.
Studied: Long-term follow-up within a large diabetes prevention programme.
Limits: An association with a recognised mechanism, not a reason to stop a prescribed medicine. It is a reason to raise testing.
Supplementing on the assumption of a shortfall
Not establishedOutside the recognised risk groups, there is no established benefit to taking B12 without a demonstrated deficiency.
Studied: Not applicable: this is the absence of a case rather than a tested one.
Limits: B12 is water-soluble and excess is generally excreted, so the main cost is usually money rather than harm.
Interpreting folate and B12 separately
Safety concernFolate supplementation can correct the anaemia of B12 deficiency while the neurological damage continues, which is why the two are interpreted together rather than in isolation 1.
Studied: Clinical review.
Limits: This is a reason for clinical interpretation of results, not a reason to avoid folate where it is indicated.
Why it gets missed
Most people assume a deficiency shows up in routine blood work. For B12 that assumption is unreliable: neurological symptoms can appear before anaemia does 1. Someone with tingling, numbness, balance problems or cognitive changes may have an entirely unremarkable blood count.
The second reason it gets missed is that the risk groups are defined by situation rather than symptoms, so nobody thinks to look.
Who has a real reason to ask
Older adults, in whom absorption declines. Anyone on long-term metformin 2. People following vegan or strictly plant-based diets, since plant foods contain essentially no B12 unless fortified. Anyone who has had bariatric surgery or has a condition affecting the stomach, because absorption depends on intrinsic factor produced there.
If you are in one of those groups, this is a specific thing to raise at an appointment.
The metformin case
This is worth singling out because it is so actionable. Long-term metformin use is associated with B12 deficiency 2, and metformin is among the most widely prescribed medicines in the world. A great many people are taking it without ever having had B12 checked.
The action is not to stop the medicine. It is to ask whether B12 should be monitored.
What we can conclude
B12 is a deficiency-first nutrient. The case for correcting a confirmed shortfall is solid and the consequences of missing one can be lasting, which puts a premium on identifying the people who should be tested. Outside those groups there is no established reason to supplement, and the honest answer to "should I take B12?" is another question: are you in one of the risk groups?
Technical layer: chemistry and pharmacokinetics
Absorption. Dietary B12 is released from food protein by gastric acid and binds intrinsic factor, a protein made by the stomach, before being absorbed in the terminal ileum. Any step in that chain can fail, which is why stomach conditions, gastric surgery and age-related changes in acid production all raise risk 1.
Why a blood count is not sufficient. The haematological and neurological consequences do not progress in step. Neurological involvement can precede anaemia, so relying on a normal full blood count to exclude deficiency is unsafe 1.
Forms. Cyanocobalamin is the most common and most stable supplement form; methylcobalamin, hydroxocobalamin and adenosylcobalamin are also sold. Marketing claims about superiority between forms outrun the comparative evidence in people with normal absorption.
